These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20625395)

  • 1. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Sakoulas G; Perencevich EN
    PLoS One; 2010 Jul; 5(7):e11432. PubMed ID: 20625395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.
    Schweizer ML; Furuno JP; Harris AD; Johnson JK; Shardell MD; McGregor JC; Thom KA; Cosgrove SE; Sakoulas G; Perencevich EN
    BMC Infect Dis; 2011 Oct; 11():279. PubMed ID: 22011388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of outcomes in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia who are treated with β-lactam vs vancomycin empiric therapy: a retrospective cohort study.
    Wong D; Wong T; Romney M; Leung V
    BMC Infect Dis; 2016 May; 16():224. PubMed ID: 27215201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
    Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
    JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
    Thom KA; Schweizer ML; Osih RB; McGregor JC; Furuno JP; Perencevich EN; Harris AD
    BMC Infect Dis; 2008 Sep; 8():116. PubMed ID: 18793400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients.
    Schweizer ML; Furuno JP; Sakoulas G; Johnson JK; Harris AD; Shardell MD; McGregor JC; Thom KA; Perencevich EN
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1082-7. PubMed ID: 21173172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia.
    Caffrey AR; Timbrook TT; Noh E; Sakoulas G; Opal SM; Nizet V; LaPlante KL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to standards of care and mortality in the management of Staphylococcus aureus bacteraemia in Peru: A prospective cohort study.
    Schwalb A; Cachay R; de la Flor A; García C; Seas C
    Int J Infect Dis; 2020 Jul; 96():601-606. PubMed ID: 32505877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
    Schreiber MP; Chan CM; Shorr AF
    J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy.
    Gómez J; García-Vázquez E; Baños R; Canteras M; Ruiz J; Baños V; Herrero JA; Valdés M
    Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):239-45. PubMed ID: 17318479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
    Roghmann MC
    Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proactive infectious disease consultation at the time of blood culture collection is associated with decreased mortality in patients with methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study.
    Kawasuji H; Sakamaki I; Kawamura T; Ueno A; Miyajima Y; Matsumoto K; Kawago K; Higashi Y; Yamamoto Y
    J Infect Chemother; 2020 Jun; 26(6):588-595. PubMed ID: 32085966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of rapid methicillin-resistant Staphylococcus aureus polymerase chain reaction testing on mortality and cost effectiveness in hospitalized patients with bacteraemia: a decision model.
    Brown J; Paladino JA
    Pharmacoeconomics; 2010; 28(7):567-75. PubMed ID: 20550222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impacts of inappropriate empirical therapy on ED patients with Staphylococcus aureus and streptococci bacteremia.
    Lee CH; Yang CY; Hsieh CC; Hong MY; Lee CC
    Am J Emerg Med; 2020 May; 38(5):940-946. PubMed ID: 31493980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia.
    Paul M; Kariv G; Goldberg E; Raskin M; Shaked H; Hazzan R; Samra Z; Paghis D; Bishara J; Leibovici L
    J Antimicrob Chemother; 2010 Dec; 65(12):2658-65. PubMed ID: 20947620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
    Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
    Khatib R; Saeed S; Sharma M; Riederer K; Fakih MG; Johnson LB
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia: the ARREST RCT.
    Thwaites GE; Scarborough M; Szubert A; Saramago Goncalves P; Soares M; Bostock J; Nsutebu E; Tilley R; Cunningham R; Greig J; Wyllie SA; Wilson P; Auckland C; Cairns J; Ward D; Lal P; Guleri A; Jenkins N; Sutton J; Wiselka M; Armando GR; Graham C; Chadwick PR; Barlow G; Gordon NC; Young B; Meisner S; McWhinney P; Price DA; Harvey D; Nayar D; Jeyaratnam D; Planche T; Minton J; Hudson F; Hopkins S; Williams J; Török ME; Llewelyn MJ; Edgeworth JD; Walker AS
    Health Technol Assess; 2018 Oct; 22(59):1-148. PubMed ID: 30382016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus.
    Harbarth S; Rutschmann O; Sudre P; Pittet D
    Arch Intern Med; 1998 Jan; 158(2):182-9. PubMed ID: 9448557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.